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Purpose: Because previous studies have reported depleted
antioxidant capacity in patients with chronic pancreatitis (CP),
prevention of free radical production has gained importance in
antifibrotic treatment strategies for CP. The aim of this study
was to investigate the effects of ascorbic acid on oxidative
capacity and pancreatic damage in experimental CP. Materials
and Methods: CP was induced in male Sprague-Dawley rats
by infusion of dibutyltin dichloride (DBTC) into the tail vein.
Ascorbic acid was given intraperitoneally at a daily dose of
10 mg/kg body weight. The treatment groups were as follows:
group 1, DBTC plus intraperitoneal physiologic saline; group
2, DBTC plus intraperitoneal ascorbic acid; group 3, solvent
plus intraperitoneal physiologic saline; group 4, no operation
plus intraperitoneal physiologic saline. Each group contained
15 animals. Treatment was started after CP was established.
After 4 weeks of treatment, serum hyaluronic acid and laminin
levels were determined by radioimmunoassay, pancreatic
tissue oxidative stress was analyzed, and the degree of pancreatic
damage was determined. Results: Ascorbic acid treatment
markedly increased superoxide dismutase (SOD) activity and
decreased malondialdehyde (MDA) concentrations in pancreatic
tissue (p < 0.01 for both). Significant serum hyaluronic acid
and laminin reductions were observed in group 2 as compared
with group 1 (p < 0.05). However, the serum hyaluronic acid
and laminin levels remained elevated when compared with
those of groups 3 and 4 (p< 0.05). Histopathologic scores were
also lower in animals with CP that underwent ascorbic
acid-treatment (p < 0.05). Conclusion: Ascorbic acid treatment
alleviated the degree of oxidative stress and pancreatic damage
in rat CP. Antioxidant treatment might be considered a
potential option to improve the pathologic process in CP.
Key Words: Ascorbic acid, chronic pancreatitis, antioxidant,
dibutyltin dichloride (DBTC)
INTRODUCTION
Chronic pancreatitis (CP) is a progressive,
chronic inflammatory disease of the pancreas
characterized by glandular atrophy, ductal changes,
and extensive fibrosis. Heightened free radical
activity and oxidative stress may be important in
the pathogenesis of CP.
1-3 In normal metabolism,
exogenous chemicals (xenobiotics) are metabolized
via the mitochondrial enzyme cytochrome P450
(cP450) pathway. During this process, reactive
oxygen free radicals are produced that are capable
of causing cell damage by peroxidation of lipids
and lipoproteins in the cell membrane. Endogenous
antioxidants, in particular, products of methionine
metabolism such as glutathione, are important in
preventing cellular damage caused by these free
radical species. Combined with a deficiency in
antioxidant defense mechanisms, increased levels
of oxygen free radicals may be capable of impairing
normal pancreatic structure and function.
4 Thus,
oxidative stress is involved not only in the
pathogenesis of acute pancreatitis, but also in the
development of pancreatic fibrosis, in which it
plays a substantial role.
5 It was demonstrated that
increased production of reactive oxygen species
(ROS) in the course of pancreatitis activates
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nuclear factor B (NF- B), which subsequently κ κ
results in the transcription of various proinflam-
matory cytokines, leading to tissue damage and
ultimately fibrosis.
6
Ascorbic acid is a well-known water-soluble
antioxidant required by all mammalian cells for
proper functioning. The antioxidant effects of
ascorbic acid have been demonstrated in many
experiments in vitro.
7 Oxidation of lipids, proteins,
and DNA results in specific oxidation products
that can be measured in the laboratory. Although
rodents (except for guinea pigs) produce ascorbate
in the liver, humans are unable to synthesize
ascorbate. Recently, Esrefoglu et al. found that
ascorbic acid and N-acetylcysteine (NAC) are
potentially capable of limiting pancreatic damage
produced during acute pancreatitis by protecting
the fine structure of acinar cells and antioxidant
enzyme activities in tissue.
8 The potential
mechanisms include promotion of the anti-
oxidizing ability of acute pancreatitis patients,
blocking lipid peroxidation in the plasma, and
improvement of cellular immune function.
9
Combined antioxidant therapy reduces pain and
improves quality of life in patients with CP.
4
Patients with CP have significantly decreased
micronutrient intake owing to diet modification
due to pain, and micronutrient deficiency might
contribute to increased oxidative stress in these
patients.
10 On the basis of the aforementioned
evidence, we reasoned that ascorbic acid might
prevent or mitigate CP induced by dibutyltin
dichloride (DBTC) in rats.
MATERIALS AND METHODS
This experiment was approved by the Institu-
tional Animal Use and Care Committee of the
School of Medicine at Zhejiang University and
performed in accordance with the National
Institutes of Health Guidelines for the Care and
Handling of Animals.
Induction of CP
Male Sprague-Dawley rats weighing 150 to 175g
were obtained from the School of Medicine,
Zhejiang University (Hangzhou, China). Before
the experiment, the animals were fed standard rat
chow and water ad libitum and housed in cages
with controlled temperature and 12-hour light/
dark cycles for at least 1 week. DBTC (Schering
AG, Berlin, Germany) was dissolved in 100%
ethanol (two parts) and then mixed with glycerol
(three parts). DBTC (8 mg/kg body wt) in a
volume of 200 L was injected into the tail vein μ
for induction of CP.
11
Experimental design
Because pancreatic fibrosis develops 2 to 3
weeks after DBTC injection,
11 treatment was
started 4 weeks after DBTC administration.
Pancreatitis was induced in groups 1 and 2.
Group 3 received 0.2 mL solvent, and group 4
consisted of normal male Sprague-Dawley rats
without DBTC or solvent. Each group included 15
animals. Rats that died within 4 weeks after DBTC
(groups 1 and 2) or solvent (group 3) adminis-
tration were replaced with new ones to maintain
15 animals in each group until the end of the
fourth week. Fifty rats in the DBTC injection
groups and 18 rats in the solvent injection group
were used in order to have 15 rats per group.
Mortality rates in the DBTC and solvent groups
were 18% (9/50) and 6% (1/18), respectively. By
the fourth week after the administration, groups
1, 3, and 4 received intraperitoneal physiologic
saline 10 mL/kg/d, and group 2 was treated with
intraperitoneal ascorbic acid at a daily dose of 10
mg/kg (Shanghai Xudong Haipu Pharmaceutical
Co., Ltd., Shanghai, China) for 4 weeks. Two rats
from group 1 and two rats from group 2, which
died between the fourth and eighth weeks, were
excluded from the study. Animals were killed by
carbon dioxide inhalation at 4 weeks. Before rats
were euthanized, blood was withdrawn by
cardiac puncture, and serum was kept at -20℃
until the assays were carried out. Pancreatic
tissues were dissected as quickly as possible, and
portions were immediately snap-frozen and
stored at -80℃ until the analyses were carried out.
Serum hyaluronic acid and laminin
The serum levels of hyaluronic acid and laminin
were determined by radioimmunoassay accordingXin-Liang Lu, et al.
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to the instructions of the manufacturer (Shanghai
Tocan Technology Co., Ltd., Shanghai, China).
Tissue oxidative stress analyses
Pancreatic tissue samples were homogenized
with physiologic saline. Superoxide dismutase
was determined using a hydroxylamine assay
developed from the xanthine oxidase assay
according to the instructions of the manufacturer
(Nanjing Jiancheng Bioengineering Institute,
Nanjing, China). SOD activity was expressed in
units per gram wet weight.
Thiobarbituric acid-reactive substance levels
were determined as previously described.
12 After
the reaction of thiobarbituric acid with malon-
dialdehyde (MDA), the reaction product was
extracted in butanol and measured spectrofluoro-
metrically (excitation, 532 nm; emission, 533 nm;
slit, 10 nm). Tetramethoxy propane solution was
used as a standard. Thiobarbituric acid-reactive
substance levels were expressed in nanomoles per
gram wet weight.
Histopathologic analysis
Paraffin-embedded tissue samples were sliced
and stained by hematoxylin-eosin and ponceau S
to visualize fibrous tissue.
13 A participating
pathologist blinded from the study protocol
evaluated all histological slides by using a
previously described scoring system
5 with modifica-
tions. Pericellular and interlobular fibrosis, collagen
content, and sublobular and lobular atrophy were
evaluated semiquantitatively (Table 1).
Statistical analysis
Values are expressed as means ± SD. An
unpaired Student’s t-test was used when two
variables were compared. When more than two
variables were present, group means were
compared using ANOVA followed by a post hoc
test. If variances were not found to meet equality
Table 1. Histopathologic Scoring System in Chronic Pancreatitis Rats
Histology Scores Definitions
Pericellular fibrosis 0
1
2
3
Absent
Fibrosis limited with 1-2 lobule (s)
Fibrosis in < 50% of lobules
Fibrosis > 50% of lobules
Interlobular fibrosis 0
1
2
3
Absent
Fibrosis between 2 and 3 lobules
Fibrosis between < 50% of lobules
Fibrosis between > 50% of lobules
Collagen content 0
1
2
3
Absent
Thin fibrous band around cells or acini
Moderate thickened fibrous band around cells or acini
Marked homogeneous collagen around cells or acini
Sublobular atrophy 0
1
2
3
Absent
Focal atrophy in 1-2 lobule (s)
Focal atrophy in < 50% of lobules
Focal atrophy in > 50% of lobules
Lobular atrophy 0
1
2
3
Absent
Total atrophy in 1-2 lobule (s)
Totally atrophic of < 50% of lobules
Totally atrophic of > 50% of lobulesAscorbic Acid Alleviates Pancreatic Damage
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criteria, variables were compared in groups of two
using a Student’s t-test. Categorical values
(histopathologic evaluation) were expressed as
median and percentiles. The Mann-Whitney U test
was used to evaluate the differences of the groups.
p < 0.05 was considered statistically significant.
RESULTS
Serum hyaluronic acid and laminin
Ascorbic acid treatment reduced hyaluronic
acid and laminin concentrations in the blood (Fig.
1). The serum hyaluronic acid levels were 114 ± 26
g/L in group 1, 80 μ ± 22 g/L in group 2, 56±20 μ
g/L in group 3, and 60 μ ± 25 g/L in group 4, μ
respectively. The serum laminin levels were 85 ±
18 g/L in group 1, 68 μ ± 15 g/L in group 2, 40 μ
± 12 g/L in group 3, and 43 μ ± 15 g/L in group μ
4. Significant serum hyaluronic acid and laminin
reductions were observed in group 2 as compared
with the levels in group 1 (p < 0.05). However, the
serum hyaluronic acid and laminin levels
remained elevated when compared with those of
groups 3 and 4 (p < 0.05).
Tissue oxidative stress analyses
Pancreatic tissue SOD enzyme activities (U/g
wet weight) and MDA levels (nmol/g wet weight)
were analyzed to determine the tissue oxidative
stress status (Fig. 2). Ascorbic acid treatment
increased the SOD levels and decreased the MDA
concentrations in pancreatic tissue. The tissue
SOD levels were 227 ± 29 U/g in group 1, 523 ± 32
U/g in group 2, 318 ± 19 U/g in group 3, and 356
± 25 U/g in group 4. The tissue MDA levels were
38 ± 3 nmol/g in group 1, 10 ± 2 nmol/g in group
2, 5 ± 1 nmol/g in group 3, and 8 ± 1 nmol/g in
group 4. SOD enzyme activities in group 1 were
significantly lower than those in group 2 (p <
0.01). MDA levels in group 1 were significantly
higher than those in group 2 (p < 0.01).
Histopathologic analyses
At the end of eighth week, segmental glandular
atrophy was prominent in group 1. Interstitial
edema, mononuclear inflammatory cell infiltration,
destruction of acini, and intralobular or interlo-
bular and periductal fibrosis were also observed
Fig. 1. Ascorbic acid treatment reduced serum hyaluronic
acid and laminin concentrations ( g/L) in experimental μ
chronic pancreatitis. Serum hyaluronic acid and laminin
analysis: group 1 vs group 3, group 1 vs group 4; p <
0.01. Group 2 vs group 1, group 2 vs group 3, group
2 vs group 4; p < 0.05. Group 3 vs group 4; p > 0.05.
Group 1, DBTC plus intraperitoneal physiologic saline;
group 2, DBTC plus intraperitoneal ascorbic acid;
group 3, solvent plus intraperitoneal physiologic saline;
group 4, no operation plus intraperitoneal physiologic
saline.
Fig. 2. Ascorbic acid treatment increased superoxide
dismutase (SOD) levels and decreased malondialdehyde
(MDA) concentrations in pancreatic tissue in experimental
chronic pancreatitis. Pancreatic tissue SOD and MDA
analysis: group 1 vs group 2, group 1 vs group 3, group
1 vs group 4; p < 0.01. Group 2 vs group 3, group 2 vs
group 4; p < 0.05. Group 3 vs group 4; p > 0.05. SOD, U/g
wet weight; MDA, 10
-10 mol/g wet weight. Group 1,
DBTC plus intraperitoneal physiologic saline; group 2,
DBTC plus intraperitoneal ascorbic acid; group 3, solvent
plus intraperitoneal physiologic saline; group 4, no opera-
tion plus intraperitoneal physiologic saline.Xin-Liang Lu, et al.
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in lobular and sublobular patterns. The animals in
groups 3 and 4 had significantly less pancreatic
injury and fibrosis when compared with those in
the other groups (p < 0.05). As demonstrated in
Table 2, the histopathologic scores were higher in
groups 1 and 2. Subgroup analysis of the
pathological scores revealed that group 2 animals
had significantly lower scores than group 1
animals (Fig. 3) (p < 0.05).
DISCUSSION
Ascorbic acid therapy improved morphological
pancreatic injury as well as markers of oxidative
stress and fibrosis in our study. Ascorbic acid is
a six-carbon lactone that is synthesized from
glucose by the liver of most mammalian species,
but not by those in humans, non-human primates,
and guinea pigs. These species do not have the
enzyme gulonolactone oxidase, which is essential
for synthesis of ascorbic acid’s immediate precursor
2-keto-l-gulonolactone. The DNA encoding
gulonolactone oxidase has undergone substantial
mutation, resulting in the absence of a functional
enzyme.
14,15 Ascorbic acid is called an antioxidant
because, by donating its electrons, it prevents
other compounds from being oxidized. However,
Fig. 3. Effect of ascorbic acid on pancreatic pathology in experimental chronic pancreatitis (hematoxylin and eosin
staining, original magnification: × 200). Group 1, DBTC plus intraperitoneal physiologic saline; group 2, DBTC plus
intraperitoneal ascorbic acid.
Table 2. Histopathologic Evaluation of Chronic Pancreatitis Rats
Group 1 Group 2 Group 3 Group 4
Pericellular fibrosis 1 (1 - 1.25) 1 (0.25 - 1) 0 (0 - 0) 0 (0 - 0)
Interlobular fibrosis 2 (0 - 3) 2 (0.25 - 3) 0.5 (0 - 1) 0 (0 - 0)
Collagen content 1 (1 - 2) 1 (1 - 2) 0.5 (0 - 1) 0.5 (0 - 1)
Sublobular atrophy 1 (0.75 - 1) 0.5 (0 - 1) 0 (0 - 1) 0 (0 - 0)
Lobular atrophy 3 (1 - 3) 1 (0 - 1.5) 0 (0 - 0) 0 (0 - 0)
Total score 8 (4.75 - 9.25) 5 (2.5 - 7) 1.0 (0 - 3) 0.5 (0 - 1)
Values are given as median (25%-75% percentiles).
Total score analysis: group 1 vs group 3, group 1 vs group 4, group 2 vs group 3, group 2 vs group 4; p < 0.01. Group 1 vs
group 2; p < 0.05. Group 3 vs group 4; p > 0.05.
Group 1, DBTC plus intraperitoneal physiologic saline; group 2, DBTC plus intraperitoneal ascorbic acid; group 3, solvent plus
intraperitoneal physiologic saline; group 4, no operation plus intraperitoneal physiologic saline.Ascorbic Acid Alleviates Pancreatic Damage
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by the very nature of this reaction, ascorbic acid
itself is oxidized in the process. It is noteworthy
that when ascorbic acid donates electrons, they
are lost sequentially. The species formed after the
loss of one electron is a free radical, semide-
hydroascorbic acid or ascorbyl radical. As
compared with other free radicals (a species with
an unpaired electron), ascorbyl radical is relatively
stable with a half-life of 10
-5 seconds and is fairly
unreactive. This property explains why ascorbate
may be a preferred antioxidant. In simple terms,
a reactive and possibly harmful free radical can
interact with ascorbate; the reactive free radical is
reduced, and the ascorbyl radical formed in its
place is less reactive. Reduction of a reactive free
radical with formation of a less reactive compound
is sometimes called free radical scavenging or
quenching. Ascorbate is therefore a good free radical
scavenger because of its chemical properties.
16,17 In
our study, ascorbic acid treatment increased SOD
levels and decreased MDA concentrations in
pancreatic tissue.
It has been increasingly recognized that
persistent oxidative stress may play a role in the
development and maintenance of CP.
1,4,5,18 Several
lines of evidence arising from clinical settings and
experimental animal models support this
argument.
3,5,19 It is well established that oxygen
radicals play an instrumental role in the develop-
ment of inflammatory tissue damage. Their
involvement in acute pancreatitis has been
studied extensively in the last decade. Braganza et
al. proposed that the root cause of pancreatic
disease is the overactivity of hepatic mixed-function
oxidases.
20 Pancreatic production of oxidized
byproducts probably occurs through the same
P4502E1 enzyme present in hepatocytes.
21 In
various experimental models, oxygen radicals
generated at an early stage of disease contribute
to the tissue damage. Because oxygen radicals
react most readily with polyunsaturated fatty
acids resulting in the peroxidation of lipids,
several studies focused on the development of
lipid peroxidation in pancreatitis. In fact, in all
experimental models of acute pancreatitis, lipid
peroxidation products increased within the
pancreatic tissue before electron and light
microscopy revealed severe damage. ROS are
normally produced in cells in a number of
biological processes where they regulate critical
physiological and pathophysiological functions.
22
Elements engaged in complex molecular machinery
that prevent ROS from becoming harmful are
termed endogenous antioxidants. Oxidative stress
is the molecular and cellular damage resulting
from excessive ROS production or from reduced
endogenous antioxidants.
Antioxidant treatment had a positive effect in
patients who suffered from pancreatic inflammatory
pain in a 1-year clinical study of antioxidant
therapy for the treatment of pain and recurrent
inflammatory episodes in patients with chronic
and acute recurrent pancreatitis using a prospective,
descriptive, pre-post, open design.
23 Another
study showed that treatment with antioxidants
may improve quality of life with regard to pain
and physical and social functioning.
4 In this study,
the degree of acinar atrophy and the amount of
pancreatic connective tissue were greatly reduced
by ascorbic acid administration, and ascorbic acid
treatment also reduced hyaluronic acid and
laminin concentrations in the blood. It has been
demonstrated that increased production of ROS in
the course of pancreatitis activates NF- B, which κ
subsequently results in the transcription of various
proinflammatory cytokines, leading to tissue
damage and ultimately fibrosis.
6 As demonstrated
in several experimental studies, inhibition of
tumor necrosis factor- (TNF-) improves survival
and prevents complications in patients with
pancreatitis.
5,18 It has been shown that antioxidant
treatment prevents NF- B activation in pancreatic κ
stellate cells (PSCs), acinar cells, and neutrophils
in acute pancreatitis.
24 Our data showed no
obvious morphological fibrosis improvement in
the ascorbic acid treatment group after 4 weeks of
therapy, but antioxidant treatment strategies can
be beneficial in reducing hyaluronic acid and
laminin concentrations in the blood even when it
is started after the establishment of profound
fibrosis.
In summary, this study demonstrated that
ascorbic acid treatment increased SOD levels and
decreased MDA concentrations in pancreatic
tissue, reduced hyaluronic acid and laminin
concentrations in the blood, and attenuated
morphological pancreatic injury in experimental
CP. Ascorbic acid treatment strategies mayXin-Liang Lu, et al.
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produce clinical benefits in the long term. A larger
and longer-term intervention trial of ascorbic acid
therapy in CP is necessary to confirm these
findings and to establish the role of this treatment
in the management of this disabling condition.
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